Local News: Arctic Region 

 | 

Sign Up

 | 

Sign In

Advertisment

Discovery Partners International

Discovery Partners International Wire

Comprehensive News Feed for Discovery Partners International.

Results 1 - 17 of 17 in Discovery Partners International

  1. Adelene Q. Perkins Named "Best Executive" at Annual Stevie(R) Awards Ceremony

    Monday Nov 16 | GlobeNewswire

    Infinity Pharmaceuticals, Inc. , an innovative cancer drug discovery and development company, today announced that Adelene Q. Perkins, president and chief business officer, was named the 2009 "Best Executive: Non-Services Business" in the 6th Annual Stevie Awards for Women in Business, presented at the Annual Award Dinner and Ceremony held on ...

    Comment?

    Related Topix: Biotech, Infinity Pharmaceuticals, Healthcare Industry

  2. Infinity Pharma 3Q loss narrows on payments

    Tuesday Nov 10 | Bioscience Technology

    Infinity Pharmaceuticals Inc. said Monday its third-quarter loss narrowed on a boost in payments from its partnership with Purdue Pharmaceutical Products LP and Mundipharma International Corp.

    Comment?

    Related Topix: Biotech, Medicine, Healthcare Industry

  3. Infinity to Present at Upcoming ConferencesRead the original story

    Tuesday Nov 10 | Digital Producer

    Infinity Pharmaceuticals, Inc. , an innovative cancer drug discovery and development company, today announced that management will present a company overview at two upcoming conferences.

    Comment?

    Related Topix: Biotech, Infinity Pharmaceuticals, Healthcare Industry

  4. Aileron Therapeutics appoints Kafka as CFO

    Oct 19, 2009 | Mass High Tech

    Protein-focused biotech company Aileron Therapeutics Inc. has named Steven Kafka as its chief financial officer and vice president of finance and operations.

    Comment?

    Related Topix: Biotech, Medicine, Healthcare Industry, Millennium Pharmaceuticals, Stanford University, Harvard University, GlaxoSmithKline

  5. Aileron Therapeutics Appoints Steven Kafka, Ph.D. as Company's First...Read the original story

    Oct 19, 2009 | BusinessWire

    Aileron Therapeutics, a biotechnology company discovering and developing a novel class of therapeutics called Stapled Peptides, announced today that it has appointed Steven Kafka, Ph.D., as the Company's first Chief Financial Officer and Vice President, Finance and Operations.

    Comment?

    Related Topix: Harvard University, Stanford University

  6. Managing capacity planning with thin provisioningRead the original story

    Oct 15, 2009 | TechTarget

    While thin provisioning is used at many sites for utilization improvements , it has another important role.

    Comment?

    Related Topix: Biotech, 3PAR, Startups, Infinity Pharmaceuticals

  7. Griffin Securities Announces Investment Opinion on Targeting Cancer Stem CellsRead the original story

    Oct 9, 2009 | Business Wire

    Griffin Securities , a research-driven investment banking firm, has released an industry report on the subject of targeting cancer stem cells .

    Comment?

    Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Merck

  8. Human Capital: People on the move, Oct. 8

    Oct 8, 2009 | Boston Business Journal

    Infinity Pharmaceuticals Inc. of Cambridge appointed Dr. Thomas Lynch a director and to the research and development committee of the board.

    Comment?

    Related Topix: Biotech, Medicine, Healthcare Industry

  9. Thomas Lynch takes board seat at Infinity Pharmaceuticals

    Oct 5, 2009 | Mass High Tech

    ... was founded in 2001. In September 2006, the company completed its acquisition of Discovery Partners International Inc., a publicly traded company based in San Diego. Following that deal, reportedly worth about $100 million, Infinity became publicly ...

    Comment?

    Related Topix: Biotech, Medicine, Healthcare Industry, Infinity Pharmaceuticals, Oncology

  10. Infinity Announces Appointment of Dr. Thomas J. Lynch to Its Board of Directors

    Oct 7, 2009 | GlobeNewswire

    Infinity Pharmaceuticals, Inc. , an innovative cancer drug discovery and development company, announced today that Thomas J. Lynch, Jr., M.D., has been appointed to its Board of Directors.

    Comment?

    Related Topix: Biotech, Infinity Pharmaceuticals, Medicine, Healthcare Industry, Health, Lung Cancer, Oncology, Yale University

  11. Infinity to Present At Upcoming Conferences

    Sep 2, 2009 | GlobeNewswire

    Infinity Pharmaceuticals, Inc. , an innovative cancer drug discovery and development company, today announced that management will present a company overview at several upcoming conferences.

    Comment?

    Related Topix: Biotech, Infinity Pharmaceuticals, Healthcare Industry

  12. Cancer Stem Cells Killed by Drug Compound, May Advance Push for TreatmentsRead the original story

    Aug 13, 2009 | Bloomberg

    Scientists said they have found a drug compound that attacks in a new way the stem cells that fuel tumor growth, opening a path to a new type of anti-cancer treatment.

    Comment?

    Related Topix: Massachusetts Institute of Technology, Cambridge, MA

  13. Drug compound that kills cancer stem cells identifiedRead the original story

    Aug 13, 2009 | Omaha World-Herald

    A drug that can selectively target and kill the stem cells that drive the growth of tumors has been identified for the first time by scientists who searched more than 16,000 compounds to find it.

    Comment?

    Related Topix: Medicine, Cancer, Health, Massachusetts Institute of Technology, Cambridge, MA

  14. Richard K. Brown, Ph.D. and John P. McDonough join CRia s Board of DirectorsRead the original story

    Aug 11, 2009 | Business Wire

    ... with large pharmaceutical companies. Additionally, he held various executive positions at Discovery Partners International from 1995-2001, including President of IRORI where he participated in a successful IPO. Prior to DPI, Dr. Brown held various ...

    Comment?

    Related Topix: Biotech, Medicine, Healthcare Industry, Scientific Instruments, Cytyc

  15. News And FDA Updates For Theravance (NASDAQ:THRX), Auxilium...

    Jul 26, 2009 | OfficialWire

    News And FDA Updates For Theravance , Auxilium , Infinity Pharma , Momenta BioMedReports.com , the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA ...

    Comment?

    Related Topix: Healthcare Law, Law, Food and Drug Administration, Startups, Theravance, Biotech, Theravance, Medicine, Auxilium Pharmaceuticals, Healthcare Industry

  16. Infinity Paper On Discovery of Its Novel Hedgehog Inhibitor, IPI-926, ...

    Jul 23, 2009 | GlobeNewswire

    Infinity Pharmaceuticals, Inc. , an innovative cancer drug discovery and development company, today announced that the chemistry and data leading to the discovery of its novel Hedgehog signaling pathway inhibitor, IPI-926, have been published in the Journal of Medicinal Chemistry.

    Comment?

    Related Topix: Biotech, Infinity Pharmaceuticals, Medicine, Cancer, Health, Chemistry, Science, Healthcare Industry, Pancreatic Cancer, Lung Cancer

  17. Infinity Pharmaceuticals Added to Russell 2000(r) Index

    Jun 29, 2009 | GlobeNewswire

    Infinity Pharmaceuticals, Inc. , an innovative cancer drug discovery and development company, today announced that it was added to the Russell 2000 Index when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes on June 26, 2009.

    Comment?

    Related Topix: Biotech, Healthcare Industry, Infinity Pharmaceuticals